http://orcid.org/0000-0002-8862-4349
References
- Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer Statistics, 2010. Ca-A Cancer J Clin. 62:10–29.
- Liang X, Li H, Li S. 2014. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol Biosyst. 10:1014–1022.
- Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, Wang J, Wu RP, Gomez F, Loo JA. 2009. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA. 106:21984–21989.
- Lv YN, Li SX, Zhai KF, Kou JP, Yu BY. 2014. Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease. Chin J Nat Med. 12:251–258.
- Pitchai D, Roy A, Banu S. 2014. In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells–a comparison with normal breast cells. Phytother Res Ptr. 28:1499.
- Tang F, Tang Q, Tian Y, Fan Q, Huang Y, Tan X. 2015. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis. J Ethnopharmacol. 176:402–412.